LumenGuides
AI-Powered Navigation System for Pulmonary Interventions
Company Overview
Snapshot
Founded in January 2025 by Limor Prigan (Ben-Asher) and Eran Yarkoni, LumenGuides operates with 1–10 employees. The company has raised $3.85 million across two funding rounds. In March 2026, LumenGuides secured a grant from the Israel Innovation Authority.
Business overview
LumenGuides develops Naviscope, an AI-powered navigation system designed to enhance bronchoscopy for accessing previously unreachable lung tumors. This single-use, autonomous endoluminal device aims to improve the safety, speed, and accuracy of pulmonary diagnostics and treatments, enabling early-stage biopsies and precise, minimally invasive interventions. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics, serving the healthcare industry with its AI-driven technology.
Strategic signal
In March 2026, LumenGuides secured a grant from the Israel Innovation Authority. This non-equity funding validates the company's innovative approach to pulmonary interventions and signals strong institutional support for its AI-powered navigation system, indicating potential for accelerated development and market entry in the health tech sector.
Log in to access full profile ›Company Intelligence Q&A
- When was LumenGuides founded?
- LumenGuides was founded in January 2025.
- Who are the founders of LumenGuides?
- LumenGuides was founded by Limor Prigan (Ben-Asher) and Eran Yarkoni.
- What is LumenGuides' primary product?
- LumenGuides has developed Naviscope, an AI-powered navigation system for pulmonary interventions designed to access hard-to-reach lung tumors.
- What was a significant recent funding event for LumenGuides?
- In March 2026, LumenGuides secured a grant from the Israel Innovation Authority.
- What is the total capital raised by LumenGuides?
- LumenGuides has raised a total of $3.85 million across two funding rounds.